Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
This study investigates the inhibitory effect of astaxanthin (AST) on testosterone-induced benign prostatic hyperplasia (BPH) in rats. Except for the sham operation, BPH model rats were randomly assigned to five groups: the BPH model control rats, AST-treated BPH model rats (20 mg/kg, 40 mg/kg, and...
Main Authors: | Liping Wang, Yiwen Hou, Rong Wang, Qi Pan, Debao Li, Han Yan, Zuyue Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/19/12/652 |
Similar Items
-
Astaxantin and Isoflavones Inhibit Benign Prostatic Hyperplasia in Rats by Reducing Oxidative Stress and Normalizing Ca/Mg Balance
by: Alexander L. Semenov, et al.
Published: (2021-12-01) -
Correlation of prostate volume with 'International Prostate Symptom Score' and 'Benign Prostatic Hyperplasia-Impact Index' in benign prostatic hyperplasia
by: D Gnyawali, et al.
Published: (2016-07-01) -
Prostate Artery Embolization: Treatment of Symptomatic Benign Prostatic Hyperplasia
by: Jin Ho Hwang, et al.
Published: (2019-07-01) -
Comparison of the pre-treatment testosterone levels in benign prostatic hyperplasia and prostate cancer patients
by: D.E. Orakwe, et al.
Published: (2017-06-01) -
Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats
by: Woo-Young Jeon, et al.
Published: (2017-08-01)